🔎 Trials Near Me

Akèy › Limfom selil mantèl › Illinois › Chicago

Etid klinik pou Limfom selil mantèl nan Chicago, IL

10 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Ap rekriteFaz 3
  • Alliance for Clinical Trials in Oncology, Chicago
  • University of Illinois, Chicago
Laj 60 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05976763

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • The University of Chicago Medical Center (UCMC), Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Robert H Lurie Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Ap rekriteFaz 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • The University of Chicago Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT04830137

Avo In R/R And Previously Untreated MCL

Ap rekriteFaz 1/2
  • University of Chicago Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT04855695

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • Northwestern Memorial Hospital, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Chicago
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Limfom selil mantèl nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.